Home  /  Resource Library  /  High Efficacy of Venetoclax Plus Obinutuzumab in Patients with Complex Karyotype (CKT) and Chronic Lymphocytic Leukemia (CLL): A Prospective Analysis From the CLL14 Trial

High Efficacy of Venetoclax Plus Obinutuzumab in Patients with Complex Karyotype (CKT) and Chronic Lymphocytic Leukemia (CLL): A Prospective Analysis From the CLL14 Trial

Results of a study examining venetoclax combined for obinutuzumab for complex karyotype related CLL.